36 results on '"Stubbins, Ryan J."'
Search Results
2. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products
3. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies
4. Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders
5. Inflammation and myeloid malignancy: quenching the flame
6. Innovations en genomique pour les maladies non diagnostiquees: le syndrome VEXAS (vacuoles intracytoplasmiques dans les progeniteurs medu0laires, E1 ubiquitine ligase, liee a l'X, syndrome auto-inflammatoire, mutation somatique)
7. Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome
8. Differentiation therapy for myeloid malignancies: beyond cytotoxicity
9. A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia
10. Familial Myeloid Neoplasms—When to Suspect and What to Do?
11. Neurologic Manifestations of Germline GATA2 Deficiency: A Report of Two Cases
12. Germline loss of function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies
13. VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation
14. A young woman with persistent sore throat, Epstein–Barr virus, lymphadenopathy, and aberrant CD4 + CD7 ‐ T‐cells
15. Chromatin Architecture Protein CTCF Plays a Role in Determining 5-Azacytidine Response of Leukemic Cells By Potentially Regulating Hoxb Genes
16. Autologous Stem Cell Transplantation for Treatment with Curative Intent in Adult Patients with Acute Lymphoblastic Lymphoma
17. Clinical Outcomes in Fresh Versus Cryopreserved Hematopoietic Stem Cell Products in British Columbia: A Retrospective Study
18. Lost in translation: cytoplasmic UBA1 and VEXAS syndrome
19. Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
20. Incidence and socioeconomic factors in older adults with acute myeloid leukaemia: Real‐world outcomes from a population‐based cohort
21. VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)
22. British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib
23. Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort
24. Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada
25. Mitochondrial metabolism: powering new directions in acute myeloid leukemia
26. Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes
27. Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder
28. Older Adults with Acute Myeloid Leukemia in Rural Areas Are Less Likely to Receive Azacitidine with Worsened Overall Survival
29. Epstein-Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature
30. Biology and Prognostic Value of N-Myristoyltransferase 1 (NMT1) and NMT2 in Acute Myeloid Leukemia (AML)
31. CD3 T-Cell Infiltrates at Diagnosis Predicts Overall Survival in Solid Organ Transplant Recipients with Post-Transplant Lymphoproliferative Disorders (PTLD)
32. Morphologic Evolution in Post-Transplant Lymphoproliferative Disorders (PTLD): A Clinicopathologic Case Series
33. N-Myristoyltransferase 2 (NMT2) Protein Levels Predict Survival in Acute Myeloid Leukemia (AML): A Novel Prognostic Biomarker
34. Epstein‐Barr virus associated smooth muscle tumors in solid organ transplant recipients: Incidence over 31 years at a single institution and review of the literature.
35. Germline loss-of-function BRCA1 and BRCA2 mutations and risk of de novo hematopoietic malignancies.
36. VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.